Blumea Balsamifera

Blumea balsamifera  DC.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym B. densiflora Hook. f. in part.
Family Compositae; Asteraceae.
Habitat Subtropical Himalayas, Nepal, Sikkim, Assam and Khasi Hills at 700–1,350 m.
English Ngai Camphor.
Ayurvedic Kukundara, Gangaapatri.
Unani Kakarondaa.
Action Tranquilizer (used in excitement and insomnia), expectorant, sudorific. Given in intestinal diseases, colic, diarrhoea. Essential oil from leaves—hypotensive.
Taxonomic Cohort Genus Blumea (5 documented species); Family Compositae (91 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Blumea balsamifera (taxonomically cited with authority DC.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Compositae; Asteraceae (primary family classification: Compositae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. densiflora Hook. f. in part, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Subtropical Himalayas, Nepal, Sikkim, Assam and Khasi Hills at 700–1,350 m.

Across classical and vernacular Indian systems of medicine, Blumea balsamifera is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Ngai Camphor; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kukundara, Gangaapatri; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Kakarondaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Blumea balsamifera are: Tranquilizer (used in excitement and insomnia), expectorant, sudorific. Given in intestinal diseases, colic, diarrhoea. Essential oil from leaves—hypotensive. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Blumea balsamifera establish the following evidence base: The plant is a source of Ngai or Blumea Camphor. Camphor occurs in all parts of the plant, but is generally extracted from leaves. Ngai Camphor oil consists almost entirely of l-borneol. It is redistilled to obtain the refined camphor for use in medicine. The dried leaves contain sesquiterpene lactones. These lactones exhibit antitumour activity against Yoshida sacoma cells in tissue culture. The plant exhibits moderate antibacterial activity against E. coli.

image2

Botanical Reference 1: Blumea balsamifera — Botanical specimen

image3

Botanical Reference 2: Blumea balsamifera — Botanical specimen

image3

Botanical Reference 3: Blumea balsamifera — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Blumea comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Blumea densiflora (Action: Juice of fresh leaves— insecticidal, mosquito repellant. The plant yields an…); Blumea eriantha (Action: Juice of the herb— carminative. A warm infusion of leaves is given as a…); Blumea fastulosa (Action: Plant—diuretic. Essential oil—CNS depressant); Blumea lacera. (Action: Plant—antipyretic. Leaf— astringent, febrifuge, diuretic, deobstruent…). Comparing Blumea balsamifera alongside its congeners in genus Blumea highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Compositae encompasses 91 documented medicinal species (5.02% of the 1,814-species flora). Other representative medicinal members of Compositae include: Acanthospermum hispidum (Trikantaka), Achillea millefolium (Milfoil), Ainsliaea aptera (Karui Buuti), Amberboa divaricata (Brahmadandi), Anacyclus pyrethrum (Aakaarakarabha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 91 medicinal species of family Compositae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Blumea balsamifera follow the plant-part modalities specified under its therapeutic action (Tranquilizer (used in excitement and insomnia), expectorant, sudorific. Given in intestinal diseases, colic, diarrhoea. Essential oil from leaves—hypotensive), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Blumea balsamifera integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top